MeadowBrook Investment Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
LMFP
HCM
AAMU
HPC
CRM
CNB
MeadowBrook Investment Advisors's ABBV Position: Q2 2026 in Review
MeadowBrook Investment Advisors held its AbbVie (ABBV) position steady in Q2 2026 at 250 shares worth $62.9K. The position accounts for 0.05% of the portfolio, ranked #177.
MeadowBrook Investment Advisors first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. The position peaked at $147K in Q4 2023. 1,174 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- MeadowBrook Investment Advisors held 250 shares of AbbVie worth $62.9K as of Q2 2026.
- MeadowBrook Investment Advisors left its AbbVie share count unchanged in Q2 2026.
- AbbVie made up 0.05% of MeadowBrook Investment Advisors's portfolio in Q2 2026, its #177 holding.
- MeadowBrook Investment Advisors first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
- MeadowBrook Investment Advisors's AbbVie position peaked at $147K in Q4 2023.
- 1,174 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on MeadowBrook Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.